arrow
E

Erika Biegelmeyer

universidade federal de são paulo (unifesp)
H指数:3
被引数:28

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immunogenicity, Safety, and Clinical Outcomes Following Homologous and Heterologous SARS-CoV-2 Vaccination Regimens in Patients with Axial Spondyloarthritis and Psoriatic Arthritis: A Prospective Observational Study from the SAFER Cohort

同源和异源SARS-CoV-2疫苗接种方案在轴性脊柱关节炎和银屑病关节炎患者中的免疫原性、安全性和临床结局:SAFER队列的前瞻性观察研究

2026-10-220
OA
Brazilian Society of Rheumatology-2025 recommendations on vaccination in immune-mediated rheumatic diseases

巴西风湿病学学会-2025年关于免疫介导性风湿病疫苗接种的建议

2026-01-230
PRE
Comparison of the immunogenicity and safety among COVID-19 vaccines ChadOx-1, CoronaVac and BNT162b2 in systemic lupus erythematosus (SLE) patients: a prospective cohort

比较COVID-19疫苗ChadOx-1、CoronaVac和BNT162b2在系统性红斑狼疮(SLE)患者中的免疫原性和安全性:一项前瞻性队列研究

2025-11-220
PRE
Immunogenicity and safety to SARS-Cov-2 vaccination in patients with systemic vasculitis

系统性血管炎患者对SARS-Cov-2疫苗接种的免疫原性和安全性

2025-11-180
OAAI
Impact of SARS-CoV-2 Vaccination on Disease Activity and Severity of COVID-19 Infection in Patients with Systemic Lupus Erythematosus: A Multicenter Cohort Study

系统性红斑狼疮患者中SARS-CoV-2疫苗接种对COVID-19感染活动性和严重程度的影响:一项多中心队列研究

2025-10-210
OAAI
Immunogenicity of SARS-CoV-2 Vaccination Schedules Including a Booster Dose in Patients with Systemic Lupus Erythematosus: Data from a Prospective Multicenter Study

系统性红斑狼疮患者SARS-CoV-2疫苗接种计划包括加强剂量的免疫原性: 来自前瞻性多中心研究的数据

2025-01-270
OAAI
Immunogenicity and Safety According to Immunosuppressive Drugs and Different COVID-19 Vaccine Platforms in Immune-Mediated Disease: Data from SAFER Cohort
2024-12-030
OAAI
Predictors of Hospitalization in Breakthrough COVID-19 among Fully Vaccinated Individuals with Immune-Mediated Rheumatic Diseases: Data from SAFER-Study
2024-09-091
OAAI
BIVALENT MRNA COVID-19 VACCINE BOOSTER DOES NOT INCREASE THE RISK OF FLARE IN RHEUMATOID ARTHRITIS PATIENTS UNDER REAL LIFE SETTING - DATA FROM SAFER STUDY

双价mRNA COVID-19疫苗加强针在真实世界环境中不会增加类风湿关节炎患者的疾病复发风险——SAFER研究数据

2024-06-010
PRE
FACTORS ASSOCIATED WITH VACCINE RESPONSE AFTER COVID VACCINE BOOSTER IN PATIENTS WITH AUTOIMMUNE DISEASES: DATA FROM MULTICENTRIC PROSPECTIVE PHASE IV SAFER STUDY

与自身免疫性疾病患者COVID疫苗加强针后疫苗应答相关的因素:来自多中心前瞻性IV期SAFER研究的数据

2024-06-010
PRE
PREDICTORS OF HOSPITALIZATION DUETO BREAKTHROUGH COVID-19 INFECTION IN PATIENTS WITH IMMUNE-MEDIATED RHEUMATIC DISEASES: DATA FROM SAFER STUDY

免疫介导性风湿病患者的突破性COVID-19感染住院预测因素:SAFER研究数据

2024-06-010
PRE